TITLE

German S3-guidelines on the treatment of psoriasis vulgaris (short version)

AUTHOR(S)
Nast, A.; Boehncke, W.; Mrowietz, U.; Ockenfels, H.; Philipp, S.; Reich, K.; Rosenbach, T.; Sammain, A.; Schlaeger, M.; Sebastian, M.; Sterry, W.; Streit, V.; Augustin, M.; Erdmann, R.; Klaus, J.; Koza, J.; Müller, S.; Orzechowski, H.; Rosumeck, S.; Schmid-Ott, G.
PUB. DATE
March 2012
SOURCE
Archives of Dermatological Research;Mar2012, Vol. 304 Issue 2, p87
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Psoriasis vulgaris is a common and often chronic inflammatory skin disease. The incidence of psoriasis in Western industrialized countries ranges from 1.5 to 2%. Patients afflicted with severe psoriasis vulgaris may experience a significant reduction in quality of life. Despite the large variety of treatment options available, patient surveys have revealed insufficient satisfaction with the efficacy of available treatments and a high rate of medication non-compliance (Richards et al. in J Am Acad Dermatol 41(4):581-583, ). To optimize the treatment of psoriasis in Germany, the Deutsche Dermatologische Gesellschaft (DDG) and the Berufsverband Deutscher Dermatologen (BVDD) have initiated a project to develop evidence-based guidelines for the management of psoriasis first published in 2006 and now updated in 2011. The Guidelines focus on induction therapy in cases of mild, moderate, and severe plaque-type psoriasis in adults. This short version of the guidelines presents the resulting series of therapeutic recommendations, which were based on a systematic literature search and discussed and approved by a team of dermatology experts. In addition to the therapeutic recommendations provided in this short version, the full version of the guidelines includes information on contraindications, adverse events, drug interactions, practicality, and costs, as well as detailed information on how best to apply the treatments described (for full version please see Nast et al. in JDDG Suppl 2:S1-S104, or ).
ACCESSION #
71882095

 

Related Articles

  • Deep endometriosis infiltrating the recto-sigmoid: critical factors to consider before management. Abrão, Mauricio Simões; Petraglia, Felice; Falcone, Tommaso; Keckstein, Joerg; Yutaka Osuga; Chapron, Charles // Human Reproduction Update;May/Jun2015, Vol. 21 Issue 3, p329 

    BACKGROUND: Deep endometriosis invading the bowel constitutes a major challenge for the gynecologist. In addition to the greater impact on pain, the high incidence of surgical morbidity involved with bowel endometriosis poses a therapeutic dilemma for the surgeon. Intestinal involvement by deep...

  • Tazarotene/corticosteroid proven superior Tx for plaque psoriasis. Guttman, Cheryl // Dermatology Times;Jun2001, Vol. 22 Issue 6, p13 

    Reports on the efficacy of switching treatment for plaque psoriasis from calcipotrine plus a corticosteroid to tazarotene 0.1 percent gel. Improvement of disease status; High level of patient satisfaction; Patient requirements; Drug tolerance.

  • Zadowolenie pacjentów z leczenia przeciwÅ‚uszczycowego: wyniki badania PSO Survey w Polsce. Szepietowski, Jacek; Reich, Adam; Palotai, Tamás; Kaszuba4, Andrzej; Chodorowska, Grażyna; Brzezińska-Wcisło, Ligia; Rudnicka, Lidia; Giemza, Tomasz // Clinical Dermatology / Dermatologia Kliniczna;2009, Vol. 11 Issue 3, p129 

    Introduction: Psoriasis is a chronic, inflammatory skin disorder affecting about 1-3% of general population. Currently available treatment modalities enable to achieve remission of psoriasis, however, the complete cure of this disease is still not possible. Objective: The aim of the study was...

  • Statins for the Prevention of Stroke: A Meta-Analysis of Randomized Controlled Trials. Wang, Wen; Zhang, Bo // PLoS ONE;Mar2014, Vol. 9 Issue 3, p1 

    Background: Stroke is a frequently encountered clinical event that has a detrimental impact on the quality of life. Evidence has increasingly shown that statins can substantially reduce the risk of coronary heart disease. However, it remains to be determined whether statins are definitively...

  • Patient Satisfaction and Quality of Life in Psoriasis and Psoriatic Arthritis. Mercy, Katherine M.; Gordon, Kenneth B.; Paller, Amy S. // JAMA: Journal of the American Medical Association;12/24/2014, Vol. 312 Issue 24, p2676 

    IMPORTANCE Psoriasis and psoriatic arthritis inflict significant morbidity. Data on undertreatment, treatment use, and treatment satisfaction are paramount to identify priority areas for advocacy, education, and research to improve patient outcomes. OBJECTIVES To determine the extent of...

  • Treatment Options for Patients with Psoriasis. Kilic, Arzu; Gul, Ulker // European Dermatology;2010, Vol. 5, p16 

    Psoriasis is a chronic inflammatory disease that is the result of complex interactions between genetic, enviromental and immunological factors. It is now accepted as a systemic disorder accompanied by co-morbidities, rather than simply a cutaneous disease. Treatment of a patient with psoriasis...

  • Current therapeutic options in psoriasis. Boca, Andreea N.; Badalica-Petrescu, Marius; Buzoianu, Anca D. // Human & Veterinary Medicine;Apr2014, Vol. 6 Issue 1, p6 

    Psoriasis is a chronic inflammatory skin disorder, affecting the population worldwide. The exact etiology of the disease remains unknown, but there is a genetic predisposition, associated with a series of immunological determinants and predisposing environmental factors, which all lead to the...

  • EVALUAREA CALITÄ‚Å¢II VIEÅ¢II PACIENÅ¢ILOR CU PSORIAZIS SEVER, ÃŽN DINAMICA PRE ÅžI POSTTERAPIE BIOLOGICÄ‚. MORARU, D.; MINCĂ, DANA GALIETA; BRÎNDUŞE, LĂCRĂMIOARA AURELIA // Acta Medica Transilvanica;dec2012, Vol. 17 Issue 4, p111 

    Psoriasis is a chronic disease that greatly influences economy and the daily life of the patients. The patients diagnosed with psoriasis live with a profound individual discomfort that is reflected on the relational life. From the esthetic point of view, or from the point of view of the...

  • Some Observations on Reporting Quality of Life in Treatment of Psoriasis in Outpatient Clinics. Lindberg, Magnus; Berg, Mats // Acta Dermato-Venereologica;2013, Vol. 93 Issue 2, p210 

    The article discusses a study on whether the Dermatology Life Quality Index (DLQI) and/or the visual analogue scale (VAS) could be recommended for use in everyday practice for treatment follow-ups in psoriasis in Swedish outpatient clinics. The DLQI is described as a quality of life instrument...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics